Other News To Note
AMAG Pharmaceuticals Inc., of Lexington, Mass., received marketing authorization in Switzerland for Reinso (ferumoxytol) for iron deficiency anemia in adults with chronic kidney disease.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.